Browsing by Title

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 3927 to 3946 of 5150 < previous   next >
Issue DateTitleAuthor(s)
2018-05-01RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancer.
2018-11Radial and femoral access for interventional fellows performing diagnostic coronary angiographies: the LEARN-Cardiogroup II, a prospective multicenter study.
2018-06Radiation dose optimisation for conventional imaging in infants and newborns using automatic dose management software: an application of the new 2013/59 EURATOM directive.
2017-02Radical vulvectomy with a bilateral pudendal flap in the treatment of a vulvar cancer la Noval, Begoña Díaz
2015-05Radiological assessment of placement of the hysteroscopically inserted Essure permanent birth control device.
2018-01Radiotherapy for isolated granulocytic sarcoma: Case report and review of literature.
2018Raltegravir plus abacavir/lamivudine in virologically suppressed HIV-1-infected patients: 48-week results of the KIRAL study.
2017Raman spectroscopic analysis of the effect of the lichenicolous fungus Xanthoriicola physciae on its lichen host.
2015-10Randomised clinical trial: conventional Lichtenstein vs. hernioplasty with self-adhesive mesh in bilateral inguinal hernia surgery.
2016Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer.
2017-05-01Randomized comparison of intravenous procainamide vs. intravenous amiodarone for the acute treatment of tolerated wide QRS tachycardia: the PROCAMIO study.
2017Randomized comparison of liposomal amphotericin B versus placebo to prevent invasive mycoses in acute lymphoblastic leukaemia.
2017Randomized phase 2 study of otlertuzumab and bendamustine versus bendamustine in patients with relapsed chronic lymphocytic leukaemia.
2017Randomized Phase II Trial of Parsatuzumab (Anti-EGFL7) or Placebo in Combination with FOLFOX and Bevacizumab for First-Line Metastatic Colorectal Cancer.
2017Randomized Phase II Trial of Parsatuzumab (Anti-EGFL7) or Placebo in Combination with FOLFOX and Bevacizumab for First-Line Metastatic Colorectal Cancer.
2017Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin study.
2015-04-09Randomized trial of primary PCI with or without routine manual thrombectomy.
2018-11Randomized, double-blind, phase two study of ruxolitinib plus regorafenib in patients with relapsed/refractory metastatic colorectal cancer.
2021-04Rangos de referencia de cadenas ligeras libres en suero de Trimero Diagnostic por turbidimetría. ¿Pueden ser universales los puntos de corte?Morales García, Luis J.; Pacheco Delgado, María S.; Servicio de Laboratorio Clínico. Hospital Universitario de Fuenlabrada
2015Rapamycin Protects from Type-I Peritoneal Membrane Failure Inhibiting the Angiogenesis, Lymphangiogenesis, and Endo-MT.